NIH Awards Lucigen $2.8M SBIR Grant for POC Influenza Test | GenomeWeb

NEW YORK (GenomeWeb News) – Lucigen today said it has been awarded a $2.8 million Small Business Innovation Research grant from the National Institutes of Health to develop a point-of-care diagnostic test for influenza.

The grant, the largest SBIR award ever received by the Middleton, Wis.-based company, will go toward the development of a molecular test for influenza A and B and respiratory syncytial virus. It will be able to test multiple RNA pathogens, Lucigen said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.